$FF
FutureFuel Corp. Stock $ff

$ff Overview Financials Valuation SEC Filings Company Website

2017 Form 10-K Financial Statement

#000143774918004879 Filed on March 16, 2018

Income Statement

Concept	2017	2016 Q4	2016 Q3
Revenue	$275.0M	$69.37M	$69.31M
YoY Change	8.62%	104.81%	-35.26%
Cost Of Revenue	$224.2M	$51.90M	$54.17M
YoY Change	17.0%	1079.55%	-44.14%
Gross Profit	$20.26M	$17.51M	$10.32M
YoY Change	-56.76%	-40.66%	18.95%
Gross Profit Margin	7.37%	25.25%	14.89%
Selling, General & Admin	$6.700M	$2.100M	$1.800M
YoY Change	-11.84%	16.67%	-10.0%
% of Gross Profit	33.07%	11.99%	17.44%
Research & Development	$3.659M	$600.0K	$688.0K
YoY Change	34.77%	0.0%	-6.78%
% of Gross Profit	18.06%	3.43%	6.67%
Depreciation & Amortization	$11.65M	$2.860M	$2.700M
YoY Change	7.63%	5.54%	3.45%
% of Gross Profit	57.47%	16.33%	26.17%
Operating Expenses	$10.37M	$2.700M	$2.478M
YoY Change	0.38%	12.5%	-9.63%
Operating Profit	$9.887M	$14.81M	$7.841M
YoY Change	-72.93%	-45.36%	32.16%
Interest Expense	$172.0K	$1.100M	$45.00K
YoY Change	-0.58%		7.14%
% of Operating Profit	1.74%	7.43%	0.57%
Other Income/Expense, Net	$6.762M	$0.00	$1.159M
YoY Change	57.88%		18.63%
Pretax Income	$16.65M	$15.80M	$9.000M
YoY Change	-59.2%	-41.48%	30.25%
Income Tax	-$6.862M	-$2.900M	-$3.868M
% Of Pretax Income	-41.22%	-18.35%	-42.98%
Net Earnings	$23.51M	$18.68M	$12.87M
YoY Change	-58.27%	-36.99%	165.32%
Net Earnings / Revenue	8.55%	26.93%	18.57%
Basic Earnings Per Share	$0.54	$0.43	$0.29
Diluted Earnings Per Share	$0.54	$0.43	$0.29
COMMON SHARES
Basic Shares Outstanding	43.68M		43.57M
Diluted Shares Outstanding	43.69M		43.57M

Balance Sheet

Concept	2017	2016 Q4	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$235.3M	$299.6M	$286.5M
YoY Change	-22.95%	32.83%	16.6%
Cash & Equivalents	$114.6M	$199.3M	$182.4M
Short-Term Investments	$120.7M	$100.3M	$104.1M
Other Short-Term Assets	$2.200M	$669.0K	$1.052M
YoY Change	-12.0%	-82.79%	-71.44%
Inventory	$43.80M	$52.09M	$47.95M
Prepaid Expenses		$1.694M	$538.0K
Receivables	$22.10M	$24.36M	$29.99M
Other Receivables	$7.000M	$20.60M	$15.30M
Total Short-Term Assets	$310.4M	$405.3M	$388.4M
YoY Change	-23.41%	12.63%	23.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$109.7M	$118.2M	$119.2M
YoY Change	-7.19%	-4.97%	-5.25%
Goodwill
YoY Change
Intangibles		$1.408M	$1.408M
YoY Change		0.0%	0.0%
Long-Term Investments
YoY Change
Other Assets	$4.100M	$3.876M	$3.733M
YoY Change	-2.38%	25.93%	26.03%
Total Long-Term Assets	$115.2M	$123.8M	$124.7M
YoY Change	-6.87%	-4.27%	-4.58%
TOTAL ASSETS
Total Short-Term Assets	$310.4M	$405.3M	$388.4M
Total Long-Term Assets	$115.2M	$123.8M	$124.7M
Total Assets	$425.6M	$529.0M	$513.0M
YoY Change	-19.55%	8.16%	15.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.60M	$22.80M	$24.59M
YoY Change	-18.67%	-33.8%	31.57%
Accrued Expenses	$2.500M	$2.627M	$6.541M
YoY Change	-3.85%	-11.73%	-4.8%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$35.30M	$144.0M	$41.30M
YoY Change	-75.49%	196.68%	25.72%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$17.60M	$3.325M	$2.999M
YoY Change	-12.44%	172.76%	85.93%
Total Long-Term Liabilities	$17.60M	$52.18M	$44.25M
YoY Change	-12.44%	12.84%	-6.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$35.30M	$144.0M	$41.30M
Total Long-Term Liabilities	$17.60M	$52.18M	$44.25M
Total Liabilities	$74.00M	$196.2M	$85.54M
YoY Change	-62.28%	107.0%	6.82%
SHAREHOLDERS EQUITY
Retained Earnings		$48.18M	$142.8M
YoY Change		-57.37%	66.07%
Common Stock		$4.000K	$4.000K
YoY Change		0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$351.6M	$332.8M	$427.5M
YoY Change
Total Liabilities & Shareholders Equity	$425.6M	$529.0M	$513.0M
YoY Change	-19.55%	8.16%	15.09%

Cashflow Statement

Concept	2017	2016 Q4	2016 Q3
OPERATING ACTIVITIES
Net Income	$23.51M	$18.68M	$12.87M
YoY Change	-58.27%	-36.99%	165.32%
Depreciation, Depletion And Amortization	$11.65M	$2.860M	$2.700M
YoY Change	7.63%	5.54%	3.45%
Cash From Operating Activities	$39.35M	$14.10M	$30.85M
YoY Change	-56.75%	-169.46%	23.1%
INVESTING ACTIVITIES
Capital Expenditures	$3.581M	-$1.390M	-$860.0K
YoY Change	-20.33%	16.81%	-48.5%
Acquisitions
YoY Change
Other Investing Activities	-$9.600M	$6.630M	-$18.55M
YoY Change	-68.74%	316.98%	-233.55%
Cash From Investing Activities	-$13.18M	$5.230M	-$19.40M
YoY Change	-62.56%	1207.5%	-258.76%
FINANCING ACTIVITIES
Cash Dividend Paid	$110.7M
YoY Change	954.87%
Common Stock Issuance & Retirement, Net	$0.00
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-110.8M	-2.440M	-2.670M
YoY Change	950.82%	-6.15%	-13.59%
NET CHANGE
Cash From Operating Activities	39.35M	14.10M	30.85M
Cash From Investing Activities	-13.18M	5.230M	-19.40M
Cash From Financing Activities	-110.8M	-2.440M	-2.670M
Net Change In Cash	-84.65M	16.89M	8.780M
YoY Change	-287.17%	-175.07%	-74.32%
FREE CASH FLOW
Cash From Operating Activities	$39.35M	$14.10M	$30.85M
Capital Expenditures	$3.581M	-$1.390M	-$860.0K
Free Cash Flow	$35.77M	$15.49M	$31.71M
YoY Change	-58.64%	-181.06%	18.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2017Q4	ff	Accrued Expenses And Other Current Liabilities Related Parties AccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
CY2016Q4	ff	Accrued Expenses And Other Current Liabilities Related Parties AccruedExpensesAndOtherCurrentLiabilitiesRelatedParties	142000
CY2017Q4	ff	Accrued Expenses And Other Currentliabilities AccruedExpensesAndOtherCurrentliabilities	2468000
CY2016Q4	ff	Accrued Expenses And Other Currentliabilities AccruedExpensesAndOtherCurrentliabilities	2485000
CY2011Q1	ff	Aggregate Amount Of Common And Preferred Stock Warrants Rights And Units Registered For Future Issuance AggregateAmountOfCommonAndPreferredStockWarrantsRightsAndUnitsRegisteredForFutureIssuance	50000000
CY2013Q1	ff	At The Market Offering Aggregate Shares Issued AtTheMarketOfferingAggregateSharesIssued	3000000
CY2011Q2	ff	At The Market Offering Maximum Shares Of Common Stock The Company May Sell AtTheMarketOfferingMaximumSharesOfCommonStockTheCompanyMaySell	3000000
CY2017Q4	ff	Blending Tax Credit BlendingTaxCredit	0
CY2015	ff	Cost Of Goods Sold Related Parties CostOfGoodsSoldRelatedParties	6662000
CY2016Q4	ff	Blending Tax Credit BlendingTaxCredit	5495000
CY2017	ff	Change In Fair Value Of Derivative Instruments And Marketable Securities ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities	-2170000
CY2016	ff	Change In Fair Value Of Derivative Instruments And Marketable Securities ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities	-3621000
CY2015	ff	Change In Fair Value Of Derivative Instruments And Marketable Securities ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities	3295000
CY2017	ff	Cost Of Goods Sold Related Parties CostOfGoodsSoldRelatedParties	26606000
CY2016	ff	Cost Of Goods Sold Related Parties CostOfGoodsSoldRelatedParties	10319000
CY2017	ff	Distribution Related Parties DistributionRelatedParties	160000
CY2016	ff	Distribution Related Parties DistributionRelatedParties	378000
CY2015	ff	Distribution Related Parties DistributionRelatedParties	405000
CY2017	ff	Excess Tax Benefit Expense From Sharebased Compensation Financing Activities ExcessTaxBenefitExpenseFromSharebasedCompensationFinancingActivities
CY2016	ff	Excess Tax Benefit Expense From Sharebased Compensation Financing Activities ExcessTaxBenefitExpenseFromSharebasedCompensationFinancingActivities	-137000
CY2015	ff	Excess Tax Benefit Expense From Sharebased Compensation Financing Activities ExcessTaxBenefitExpenseFromSharebasedCompensationFinancingActivities	-344000
CY2017	ff	Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties	-142000
CY2016	ff	Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties	142000
CY2015	ff	Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties	-46000
CY2017	ff	Increase Decrease Prepaid Expenses Related Parties IncreaseDecreasePrepaidExpensesRelatedParties
CY2016	ff	Increase Decrease Prepaid Expenses Related Parties IncreaseDecreasePrepaidExpensesRelatedParties	-23000
CY2015	ff	Increase Decrease Prepaid Expenses Related Parties IncreaseDecreasePrepaidExpensesRelatedParties	35000
CY2013Q1	ff	Net Proceeds From Issuance Of Common Stock After Commissions And Fees NetProceedsFromIssuanceOfCommonStockAfterCommissionsAndFees	36127000
CY2006Q3	ff	Number Of Shares Of Common Stock Subject To Registration Rights Agreement NumberOfSharesOfCommonStockSubjectToRegistrationRightsAgreement	16250000
CY2017Q4	ff	Prepaid Expenses Related Parties PrepaidExpensesRelatedParties	12000
CY2016Q4	ff	Prepaid Expenses Related Parties PrepaidExpensesRelatedParties	12000
CY2017	ff	Sales Revenue Net Excluding Revenue From Related Parties SalesRevenueNetExcludingRevenueFromRelatedParties	273144000
CY2016	ff	Sales Revenue Net Excluding Revenue From Related Parties SalesRevenueNetExcludingRevenueFromRelatedParties	244822000
CY2015	ff	Sales Revenue Net Excluding Revenue From Related Parties SalesRevenueNetExcludingRevenueFromRelatedParties	234630000
CY2017	ff	Share Based Compensation Arrangement By Share Based Payment Award Award Term ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTerm	P10Y
CY2016	ff	Sharebased Compensation Stock Options Exercised Tax SharebasedCompensationStockOptionsExercisedTax	23000
CY2017	ff	Undistributed Earnings Loss Reallocated To Participating Securities UndistributedEarningsLossReallocatedToParticipatingSecurities	21000
CY2016	ff	Undistributed Earnings Loss Reallocated To Participating Securities UndistributedEarningsLossReallocatedToParticipatingSecurities	-264000
CY2015	ff	Undistributed Earnings Loss Reallocated To Participating Securities UndistributedEarningsLossReallocatedToParticipatingSecurities	237000
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	18396000
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	22799000
CY2017Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1183000
CY2016Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1254000
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21973000
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24359000
CY2017Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	165000
CY2016Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	385000
CY2017Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	1387000
CY2016Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	1428000
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2468000
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2627000
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	90770000
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	79432000
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	8433000
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3540000
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	281964000
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	281087000
CY2015	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-344000
CY2016	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-137000
CY2015	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	120000
CY2016	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	128000
CY2017	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	121000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2043000
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1908000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	998000
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	998000
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1908000
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2043000
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2017	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	145000
CY2016	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	144000
CY2015	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7500
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	65000
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	97500
CY2017	us-gaap	Asset Impairment Charges AssetImpairmentCharges	28000
CY2016	us-gaap	Asset Impairment Charges AssetImpairmentCharges	178000
CY2015	us-gaap	Asset Impairment Charges AssetImpairmentCharges
CY2017Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	876000
CY2016Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	849000
CY2015Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	822000
CY2017	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	27000
CY2016	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	27000
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q4	us-gaap	Assets Assets	425563000
CY2016Q4	us-gaap	Assets Assets	529043000
CY2017Q4	us-gaap	Assets Current AssetsCurrent	310358000
CY2016Q4	us-gaap	Assets Current AssetsCurrent	405282000
CY2017Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	115205000
CY2016Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	123761000
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	124000
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	14103000
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	31126000
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	2903000
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0
CY2017	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	248000
CY2016	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	728000
CY2015	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	2402000
CY2017Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	26656000
CY2016Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	26171000
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid
CY2016	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	471000
CY2015	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	114627000
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	199272000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	154049000
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	124079000
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-84645000
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	45223000
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	29970000
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43741670
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43749970
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43741670
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43749970
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	4000
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	4000
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	28404000
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	57826000
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	44217000
CY2017	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt 4.65pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Custome</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">r</div><div style="display: inline; font-style: italic;"> </div><div style="display: inline; font-style: italic;">concentrations</div></div></div> <div style=" margin: 0pt 4.65pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt 4.65pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Significan<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">t portions of FutureFuel’s sales are made to a relatively small number of customers. Sales to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> biodiesel customer totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$38,917,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$35,568,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$33,255</div> for the years ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> respectively. Additionally, sales of biodiesel, petrodiesel, petrodiesel blends, and other petroleum products to a related party totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$64,981</div> for the year ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2015. </div>For the periods ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> sales to the related party were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of revenue. See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19</div> below.</div></div> <div style=" margin: 0pt 7.65pt 0pt 5.45pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt 4.65pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> of our customers<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">, DowDupont Inc. and its affiliates, represented approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30%</div> of our chemicals revenue (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> of total revenues). We sell multiple products to various affiliates of this customer under both long-term and short-term contracts. FutureFuel believes the loss of this customer would have a material impact on our financials temporarily while we sought to source other custom chemical contracts for this equipment. In the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2016, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">none</div> of our customers represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> or more of total revenues. F</div>or the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2015, </div>sales to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> biodiesel customer was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19%</div> of biofuel revenues (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> of total revenues). <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> Additionally, sales of biodiesel, petrodiesel, petrodiesel blends and other petroleum products to a related party totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37%</div> of biofuels revenue (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22%</div> of total revenue). </div></div></div></div>
CY2017Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	808000
CY2016Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2271000
CY2017	us-gaap	Cost Of Goods Sold CostOfGoodsSold	224249000
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	191662000
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	233063000
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	5766000
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-13014000
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	7475000
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	560000
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-1120000
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	487000
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-12213000
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1437000
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2283000
CY2017Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	144000
CY2016Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	144000
CY2017Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	180000
CY2016Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	325000
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-13657000
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5271000
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3721000
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	29302000
CY2016Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	45703000
CY2017Q4	us-gaap	Deferred Revenue DeferredRevenue	19258000
CY2016Q4	us-gaap	Deferred Revenue DeferredRevenue	22322000
CY2015Q4	us-gaap	Deferred Revenue DeferredRevenue	18588000
CY2017	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	2428000
CY2016	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	7752000
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2736000
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5530000
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	16522000
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	16792000
CY2017	us-gaap	Deferred Revenue Refund Payments1 DeferredRevenueRefundPayments1
CY2016	us-gaap	Deferred Revenue Refund Payments1 DeferredRevenueRefundPayments1
CY2017	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	5492000
CY2016	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	4018000
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-975000
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	36000
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-231000
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	4809000
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	9388000
CY2017Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	252000
CY2016Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	90000
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8253000
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13639000
CY2017Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	502000
CY2016Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1149000
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	609000
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2546000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	143000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	77000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1674000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Asset Retirement Obligations DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAssetRetirementObligations	201000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Asset Retirement Obligations DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAssetRetirementObligations	299000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	63000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	90000
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	21049000
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	32064000
CY2017Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	3342000
CY2016Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	5821000
CY2017Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	2285000
CY2016Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	1376000
CY2017Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	21049000
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	32064000
CY2017Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	382000
CY2016Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	213000
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	23293000
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	38293000
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1632000
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1540000
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1648000
CY2017	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.06
CY2016	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.06
CY2015	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.06
CY2017	us-gaap	Depreciation Depreciation	11617000
CY2016	us-gaap	Depreciation Depreciation	10819000
CY2015	us-gaap	Depreciation Depreciation	10187000
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11617000
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10819000
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10187000
CY2017Q4	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	-2428000
CY2016Q4	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	-258000
CY2017	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-3844000
CY2016	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-6220000
CY2015	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	9101000
CY2017	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div>)        Recently issued accounting standards</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; min-width: 700px;"> <tr> <td style="width: 16.1%; vertical-align: middle; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Standard</div></div> </td> <td style="width: 2.6%; vertical-align: middle; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 31.1%; vertical-align: middle; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Description</div></div> </td> <td style="width: 2.4%; vertical-align: middle; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 14.6%; vertical-align: middle; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Effective Date</div></div> </td> <td style="width: 2.6%; vertical-align: middle; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 30.5%; vertical-align: middle; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Effect on the Financial Statements </div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">or Other Significant Matters</div></div> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="width: 16.1%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> February 2018, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> Income Statement-Reporting Comprehensive Income: Reclassification of Certain Tax Effects from Accumulated Other<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> Comprehensive Income.</div></div> </td> <td style="width: 2.6%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 31.1%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The ASU allows reclassification from accumulated other comprehensive income/loss to retained earnings for stranded tax effects resulting from the newly enacted federal corporate tax rate. The amendments in this update should be applied retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> is recognized.</div> </td> <td style="width: 2.4%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 14.6%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Annual periods beginning after <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 15, 2018. </div>Early adoption is permitted.</div> </td> <td style="width: 2.6%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 30.5%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The Company early adopt<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">ed this guidance retrospectively, which resulted in an immaterial financial statement impact. Refer to Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div> for more information on the provisions of the Tax Cuts and Jobs Act and its impact to the Company’s financial condition and results of operations. </div></div> </td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="width: 16.1%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> Leases.</div> </td> <td style="width: 2.6%; vertical-align: top;"> </td> <td style="width: 31.1%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The new guidance supersedes the lease guidance under FASB<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">  ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">840,</div> Leases, resulting in the creation of FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842,</div> Leases. The guidance requires a lessee to recognize in the statement of financial position a liability to make lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term for both finance and operating leases.</div></div> </td> <td style="width: 2.4%; vertical-align: top;"> </td> <td style="width: 14.6%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Annual periods beginning after <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 15, 2018. </div>Early adoption is permitted.</div> </td> <td style="width: 2.6%; vertical-align: top;"> </td> <td style="width: 30.5%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The Company is currently evaluating its population of leases, and is continuing to assess all potential impacts of the standard, but currently believes the most significant impact relates to its accounting for logistics equipment. The Company anticipates recognition of additional assets and corresponding liabilities related to leases upon adoption. The Company plans to adopt the standard effective <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> January 1, 2019.</div></div> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="width: 16.1%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> May 2014, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> Revenue from Contracts with Customers. Since that date, the FASB has issued additional ASUs clarifying certain aspects of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div></div> </td> <td style="width: 2.6%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 31.1%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The core principle of this guidance is that an<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. To achieve the core principle, the guidance establishes the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> steps: <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) identify the contract(s) with a customer, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) identify the performance obligation in the contract, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>) determine the transaction price, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>) allocate the transaction price to the performance obligations in the contract, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div>) recognize revenue when (or as) the entity satisfies a performance obligation. The guidance also details the accounting treatment for costs to obtain or fulfill a contract. Lastly, disclosure requirements have been enhanced to provide sufficient information to enable users of financial statements to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers.</div></div> </td> <td style="width: 2.4%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 14.6%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Annual periods beginning after <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 15, 2017. </div>Earlier adoption was permitted, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> before <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 15, 2016.</div></div> </td> <td style="width: 2.6%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 30.5%; vertical-align: top;">Effective <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> January 1, 2018, </div>FutureFuel is required to adopt the new guidance of ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> Revenue from Contracts with Customers (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>), which will supersede the revenue recognition requirements in ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605,</div> Revenue Recognition. Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> requires the Company to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The new guidance requires FutureFuel to apply the following steps: (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) identify the contract with a customer; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) identify the performance obligations in the contract; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>) determine the transaction price; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>) allocate the transaction price to the performance obligations in the contract; and (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div>) recognize revenue when, or as, FutureFuel satisfies a performance obligation.<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> FutureFuel is in the process of evaluating all contracts, implementing additional controls, and has completed an initial assessment of its custom chemical contracts.  The Company expects that the majority of its custom chemical contracts will continue to recognize revenue at a point in time consistent with ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605.</div>  Under Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> certain custom chemical contracts, which have an upfront capital payment will account for the upfront capital payment as a material right.  FutureFuel expects to apply the renewal option approach in allocating the transaction price to the material right.  The Company will adopt Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> on a modified retrospective basis and provide additional disclosures of the amount by which each financial statement line item is affected in the current reporting period, as compared to the guidance that was in effect before the change, and an explanation of the reasons for significant changes. The adoption of this new guidance will require expanded disclosures in its consolidated financial statements.</div></td> </tr> </table> <div style=" margin: 0pt 15pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> </div></div>
CY2017	us-gaap	Distributed Earnings DistributedEarnings	6000
CY2016	us-gaap	Distributed Earnings DistributedEarnings	377000
CY2015	us-gaap	Distributed Earnings DistributedEarnings	66000
CY2015	us-gaap	Dividends Dividends	10493000
CY2016	us-gaap	Dividends Dividends	121181000
CY2017	us-gaap	Dividends Dividends	10498000
CY2017Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	10498000
CY2016Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	110688000
CY2017Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	10498000
CY2016Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	110688000
CY2015Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.29
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.06
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.06
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.36
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	976000
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	864000
CY2017Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0
CY2017	us-gaap	Gain Loss On Investments GainLossOnInvestments	127000
CY2016	us-gaap	Gain Loss On Investments GainLossOnInvestments	843000
CY2015	us-gaap	Gain Loss On Investments GainLossOnInvestments	713000
CY2017	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-195000
CY2016	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-147000
CY2015	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-178000
CY2016	us-gaap	Income Tax Reconciliation Deductions Dividends IncomeTaxReconciliationDeductionsDividends	730000
CY2015	us-gaap	Gross Profit GrossProfit	57046000
CY2017Q1	us-gaap	Gross Profit GrossProfit	6130000
CY2017Q2	us-gaap	Gross Profit GrossProfit	1798000
CY2017Q3	us-gaap	Gross Profit GrossProfit	5526000
CY2017Q4	us-gaap	Gross Profit GrossProfit	6807000
CY2016Q1	us-gaap	Gross Profit GrossProfit	11053000
CY2017	us-gaap	Gross Profit GrossProfit	20261000
CY2016	us-gaap	Gross Profit GrossProfit	46858000
CY2015	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate
CY2016Q2	us-gaap	Gross Profit GrossProfit	7972000
CY2016Q3	us-gaap	Gross Profit GrossProfit	10319000
CY2016Q4	us-gaap	Gross Profit GrossProfit	17514000
CY2016	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2017	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2017	us-gaap	Impairment Of Investments ImpairmentOfInvestments	814000
CY2016	us-gaap	Impairment Of Investments ImpairmentOfInvestments	2184000
CY2015	us-gaap	Impairment Of Investments ImpairmentOfInvestments	606000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	16649000
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	40806000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	51869000
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6862000
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15535000
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5448000
CY2017	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	-12066000
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-12066000
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate
CY2017	us-gaap	Income Tax Reconciliation Deductions Dividends IncomeTaxReconciliationDeductionsDividends	865000
CY2015	us-gaap	Income Tax Reconciliation Deductions Dividends IncomeTaxReconciliationDeductionsDividends	427000
CY2017	us-gaap	Income Tax Reconciliation Deductions Qualified Production Activities IncomeTaxReconciliationDeductionsQualifiedProductionActivities	85000
CY2016	us-gaap	Income Tax Reconciliation Deductions Qualified Production Activities IncomeTaxReconciliationDeductionsQualifiedProductionActivities
CY2015	us-gaap	Income Tax Reconciliation Deductions Qualified Production Activities IncomeTaxReconciliationDeductionsQualifiedProductionActivities	163000
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	5788000
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	14282000
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	18154000
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	191000
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	193000
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-747000
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-161000
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-94000
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-288000
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	463000
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1262000
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	695000
CY2017	us-gaap	Income Tax Reconciliation Tax Contingencies Domestic IncomeTaxReconciliationTaxContingenciesDomestic
CY2016	us-gaap	Income Tax Reconciliation Tax Contingencies Domestic IncomeTaxReconciliationTaxContingenciesDomestic	-20048000
CY2015	us-gaap	Income Tax Reconciliation Tax Contingencies Domestic IncomeTaxReconciliationTaxContingenciesDomestic	-9958000
CY2017	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal
CY2016	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	-6845000
CY2015	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	-792000
CY2017	us-gaap	Income Tax Reconciliation Tax Credits Other IncomeTaxReconciliationTaxCreditsOther
CY2016	us-gaap	Income Tax Reconciliation Tax Credits Other IncomeTaxReconciliationTaxCreditsOther	975000
CY2015	us-gaap	Income Tax Reconciliation Tax Credits Other IncomeTaxReconciliationTaxCreditsOther	975000
CY2017	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	127000
CY2016	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	56000
CY2015	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	51000
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	55000
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	987000
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	13381000
CY2017Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	6937000
CY2016Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	20508000
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4403000
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-11643000
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4056000
CY2017	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-71000
CY2016	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	1010000
CY2015	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-2668000
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2386000
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-21960000
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3816000
CY2017	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-220000
CY2016	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	375000
CY2015	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-1163000
CY2017	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-16000
CY2016	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	110000
CY2015	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-30000
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	60000
CY2016	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-645000
CY2015	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1673000
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-4215000
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3734000
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	721000
CY2017	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-13571000
CY2016	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	6394000
CY2015	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-5602000
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-8339000
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-12864000
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19604000
CY2017	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2160000
CY2016	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1762000
CY2015	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2831000
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	9000
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	556000
CY2015	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	668000
CY2017	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-34000
CY2016	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	52000
CY2015	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-28000
CY2017	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	1901000
CY2016	us-gaap	Interest Expense InterestExpense	173000
CY2015	us-gaap	Interest Expense InterestExpense	134000
CY2016	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	535000
CY2015	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	-1239000
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	9408
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4753
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	13581
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1408000
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1408000
CY2017	us-gaap	Interest Expense InterestExpense	172000
CY2017	us-gaap	Interest Expense Other InterestExpenseOther	27000
CY2016	us-gaap	Interest Expense Other InterestExpenseOther	27000
CY2015	us-gaap	Interest Expense Other InterestExpenseOther	26000
CY2017	us-gaap	Interest Paid Net InterestPaidNet
CY2016	us-gaap	Interest Paid Net InterestPaidNet
CY2015	us-gaap	Interest Paid Net InterestPaidNet
CY2017Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	22998000
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	27971000
CY2017Q4	us-gaap	Inventory Gross InventoryGross	51876000
CY2016Q4	us-gaap	Inventory Gross InventoryGross	55011000
CY2017Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	8122000
CY2016Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	2918000
CY2017Q4	us-gaap	Inventory Net InventoryNet	43754000
CY2016Q4	us-gaap	Inventory Net InventoryNet	52093000
CY2017Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	27143000
CY2016Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	25127000
CY2017Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1735000
CY2016Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1913000
CY2017	us-gaap	Inventory Write Down InventoryWriteDown	276000
CY2016	us-gaap	Inventory Write Down InventoryWriteDown	1435000
CY2017	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	7809000
CY2016	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	6152000
CY2015	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	5106000
CY2017	us-gaap	Investment Income Net InvestmentIncomeNet	7809000
CY2016	us-gaap	Investment Income Net InvestmentIncomeNet	6152000
CY2015	us-gaap	Investment Income Net InvestmentIncomeNet	5213000
CY2017	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4153000
CY2016	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4921000
CY2015	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4955000
CY2017Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	5862000
CY2016Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	5741000
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	952000
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1121000
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1060000
CY2017Q4	us-gaap	Liabilities Liabilities	73967000
CY2016Q4	us-gaap	Liabilities Liabilities	196230000
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	425563000
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	529043000
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	35281000
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	144049000
CY2017Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	38686000
CY2016Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	52181000
CY2017Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	0
CY2016Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	1151000
CY2017Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	167179000
CY2016Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	163401000
CY2017Q4	us-gaap	Marketable Securities MarketableSecurities	107357000
CY2016Q4	us-gaap	Marketable Securities MarketableSecurities	100339000
CY2017Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	120699000
CY2016Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	106146000
CY2017	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-687000
CY2016	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1340000
CY2015	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	107000
CY2017	us-gaap	Nature Of Operations NatureOfOperations	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt 0pt 0pt 5.45pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)        Nature of operations and basis of presentation</div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt 0pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Vicero</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">y</div><div style="display: inline; font-style: italic;"> </div><div style="display: inline; font-style: italic;">Acquisitio</div><div style="display: inline; font-style: italic;">n</div><div style="display: inline; font-style: italic;"> </div><div style="display: inline; font-style: italic;">Corporation</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt 4.05pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Viceroy<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> Acquisition Corporation (“Viceroy”) was incorporated under the laws of the state of Delaware on <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> August 12, 2005 </div>to serve as a vehicle for the acquisition of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> or more operating businesses in the oil and gas industry. On <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> July 12, 2006, </div>Viceroy completed an equity offering (see Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16</div>).</div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt 11.25pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">O<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">n <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> October 31, 2006, </div>Viceroy acquired all of the issued and outstanding shares of Eastman SE, Inc. (“Eastman SE”) from Eastman Chemical Company (“Eastman Chemical”). Immediately subsequent to the acquisition, Viceroy changed its name to FutureFuel Corp. (“FutureFuel”) and Eastman SE changed its name to FutureFuel Chemical Company (“FutureFuel Chemical”).</div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt 0pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Eastma</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">n</div><div style="display: inline; font-style: italic;"> </div><div style="display: inline; font-style: italic;">SE</div><div style="display: inline; font-style: italic;">,</div><div style="display: inline; font-style: italic;"> </div><div style="display: inline; font-style: italic;">Inc.</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt 16.5pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Eastma<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">n SE was incorporated under the laws of the state of Delaware on <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> September 1, 2005 </div>and subsequent thereto operated as a wholly-owned subsidiary of Eastman Chemical through <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> October 31, 2006. </div>Eastman SE was incorporated for purposes of effecting a sale of Eastman Chemical’s manufacturing facility in Batesville, Arkansas (the “Batesville Plant”).</div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt 4.65pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Th<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">e Batesville Plant was constructed to produce proprietary photographic chemicals for Eastman Kodak Company (“Eastman Kodak”). Over the years, Eastman Kodak shifted the plant’s focus away from the photographic imaging business to the custom synthesis of fine chemicals and organic chemical intermediates used in a variety of end markets, including paints and coatings, plastics and polymers, pharmaceuticals, food supplements, household detergents, and agricultural products.</div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt 8.2pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">I<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">n <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005,</div> the Batesville Plant began the implementation of a bio-based products platform. This included the production of biofuels (biodiesel) and bio-based specialty chemical products (bio-based solvents, chemicals, and intermediates). In addition to bio-based products, the Batesville Plant continues to manufacture specialty and other organic chemicals.</div></div></div>
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-110809000
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10545000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	23511000
CY2016	us-gaap	Net Income Loss NetIncomeLoss	56341000
CY2015	us-gaap	Net Income Loss NetIncomeLoss	46421000
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	3396000
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	834000
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	3334000
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	15947000
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	10569000
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11678000
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13183000
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35207000
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2025000
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	39347000
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	90975000
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	39623000
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	14224000
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	12868000
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	18680000
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6762000
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4283000
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4898000
CY2017	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2017	us-gaap	Operating Expenses OperatingExpenses	10374000
CY2016	us-gaap	Operating Expenses OperatingExpenses	10335000
CY2015	us-gaap	Operating Expenses OperatingExpenses	10075000
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	9887000
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	36523000
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	46971000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1154000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	605000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	95000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	95000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	95000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	145000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	119000
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	105000
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	335000
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	387000
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	669000
CY2017Q4	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	120699000
CY2016Q4	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	106146000
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3882000
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3876000
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2204000
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1485000
CY2017	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	121000
CY2015	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	120000
CY2015Q2	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1408000
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1408000
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4893000
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4893000
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1485000
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2204000
CY2017	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	529000
CY2016	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	1419000
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	394000
CY2017	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	285000
CY2016	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	765000
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	212000
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	7535000
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	2643000
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-3518000
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	4893000
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1485000
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2204000
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	2642000
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	1158000
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-1314000
CY2017	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2066000
CY2016	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2176000
CY2015	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2164000
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1115000
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3325000
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-188000
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-356000
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-181000
CY2017	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1047000
CY2016	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1869000
CY2015	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-315000
CY2017	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	23484000
CY2016	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	56228000
CY2015	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	46118000
CY2017	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	23484000
CY2016	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	56228000
CY2015	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	46118000
CY2017	us-gaap	Payments Of Dividends PaymentsOfDividends	110688000
CY2016	us-gaap	Payments Of Dividends PaymentsOfDividends	10493000
CY2015	us-gaap	Payments Of Dividends PaymentsOfDividends	10493000
CY2017	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts
CY2016	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts
CY2015	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	721000
CY2016	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	128000
CY2017	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	30959000
CY2016	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	60664000
CY2015	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	39136000
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3581000
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4495000
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7222000
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2017Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1660000
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1694000
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	213000
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2017	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	23254000
CY2016	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	30487000
CY2015	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	48546000
CY2017	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4000
CY2016	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	6000
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	213000
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	109735000
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	118152000
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	11.68
CY2017	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	496000
CY2016	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	523000
CY2015	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	215000
CY2017	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	496000
CY2016	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	523000
CY2015	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	215000
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3659000
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2715000
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2741000
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	11.45
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2660000
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	758000
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	61195000
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	48182000
CY2017	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1882000
CY2016	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	8371000
CY2015	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	64981000
CY2017	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt 4.65pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Deferred</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"> </div><div style="display: inline; font-style: italic;">revenue</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt 4.65pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">FutureFue<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">l has signed contracts with customers to construct plant and related assets on FutureFuel’s property for the manufacture of custom chemicals. The cost of construction has been funded by the customers with title and risk of loss to the equipment residing with FutureFuel. Reimbursements are recognized as deferred revenue and are amortized over the expected life of the customer relationship starting upon the completion of construction and the asset being placed into service.</div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt 4.65pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Additionally<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">, FutureFuel has been awarded grants from governmental agencies related to the construction of production equipment and infrastructural improvements at its plant site. The cost of construction of these projects has been either funded by the governmental agencies directly or funded by FutureFuel who has then been reimbursed by the governmental agencies. Direct payments and reimbursements for construction costs have been recognized as deferred revenue and will be amortized into earnings over the expected life of the applicable customer relationship or the life of the asset if <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> direct customer relationship is tied to the asset. Such amortization will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> begin until the asset has been placed into service and all contingencies associated with the grants are fulfilled.</div></div></div></div></div></div>
CY2017Q1	us-gaap	Revenues Revenues	54111000
CY2017Q2	us-gaap	Revenues Revenues	68048000
CY2017Q3	us-gaap	Revenues Revenues	77606000
CY2017Q4	us-gaap	Revenues Revenues	75261000
CY2016Q1	us-gaap	Revenues Revenues	46635000
CY2016Q2	us-gaap	Revenues Revenues	67879000
CY2016Q3	us-gaap	Revenues Revenues	69306000
CY2016Q4	us-gaap	Revenues Revenues	69373000
CY2017	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	275026000
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	253193000
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	299611000
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	0
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.77
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.05
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.48
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.48
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.1
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	0
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	26000
CY2014Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	90000
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	70000
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	70000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	0
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	998000
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	1908000
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	2043000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	60000
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	12.74
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	30000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.55
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	113000
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	102000
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	240000
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	250000
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	13.99
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2017Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	70000
CY2017Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	70000
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	113000
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	60000
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	30000
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
CY2014Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.78
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.78
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.78
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y335D
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y335D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P335D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y135D
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	60000
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	30000
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	30000
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	3.67
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.78
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.78
CY2017Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	12.48
CY2017Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	12.48
CY2017	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y135D
CY2017	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	3750000
CY2016	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	3976000
CY2015	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	2435000
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	20000
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	120000
CY2013Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	37247000
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	213000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	351596000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	332813000
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	359009000
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	394312000
CY2017	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	21000
CY2016	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	-264000
CY2015	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	237000
CY2017	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	21000
CY2016	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	-264000
CY2015	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	237000
CY2017	us-gaap	Unrealized Gain On Securities UnrealizedGainOnSecurities	14073000
CY2016	us-gaap	Unrealized Gain On Securities UnrealizedGainOnSecurities	6844000
CY2017	us-gaap	Unrealized Loss On Securities UnrealizedLossOnSecurities	731000
CY2016	us-gaap	Unrealized Loss On Securities UnrealizedLossOnSecurities	1037000
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2056000
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4588000
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2981000
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	2056000
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	4588000
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	2981000
CY2017Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2016Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	193000
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2056000
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1471000
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	3117000
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt 0pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Us</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">e</div><div style="display: inline; font-style: italic;"> </div><div style="display: inline; font-style: italic;">o</div><div style="display: inline; font-style: italic;">f</div><div style="display: inline; font-style: italic;"> </div><div style="display: inline; font-style: italic;">estimates</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt 4.05pt 0pt 33.95pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Th<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">e preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during a reporting period. Estimates are used when accounting for allowance for doubtful accounts, depreciation, amortization, asset retirement obligations, and income taxes as well as the evaluation of potential losses due to impairments or future liabilities. Actual results could differ materially from those estimates.</div></div></div></div></div></div>
CY2016Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4481000
CY2017Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	9859000
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	5035000
CY2014Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	9924000
CY2017	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	5378000
CY2016	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	341000
CY2015	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	75000
CY2017	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions
CY2016	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	895000
CY2015	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	4964000
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43685579
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43547538
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43445730
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43676171
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43542785
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43432149

Files In Submission

Name	View Source	Status
0001437749-18-004879-index-headers.html	Edgar Link	pending
0001437749-18-004879-index.html	Edgar Link	pending
0001437749-18-004879.txt	Edgar Link	pending
0001437749-18-004879-xbrl.zip	Edgar Link	pending
ex_107385.htm	Edgar Link	pending
ex_107386.htm	Edgar Link	pending
ex_107387.htm	Edgar Link	pending
ex_107388.htm	Edgar Link	pending
ex_107389.htm	Edgar Link	pending
ex_107390.htm	Edgar Link	pending
ff-20171231.xml	Edgar Link	completed
ff-20171231.xsd	Edgar Link	pending
ff-20171231_cal.xml	Edgar Link	unprocessable
ff-20171231_def.xml	Edgar Link	unprocessable
ff-20171231_lab.xml	Edgar Link	unprocessable
ff-20171231_pre.xml	Edgar Link	unprocessable
ff20171231_10k.htm	Edgar Link	pending
ff20171231_10k.jpg	Edgar Link	pending
ffgr1.jpg	Edgar Link	pending
ffgr2.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FF
FutureFuel Corp. Stock $ff

2017 Form 10-K Financial Statement

#000143774918004879 Filed on March 16, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FF FutureFuel Corp. Stock $ff

2017 Form 10-K Financial Statement

#000143774918004879 Filed on March 16, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FF
FutureFuel Corp. Stock $ff